Wendell David Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.5M Sell
100,552
-100
-0.1% -$23.3K 2.7% 9
2026
Q1
$24.6M Buy
100,652
+148
+0.1% +$34.5K 2.68% 9
2025
Q4
$20.8M Sell
100,504
-3,253
-3% -$643K 2.11% 14
2025
Q3
$19.2M Sell
103,757
-75
-0.1% -$12.8K 1.9% 15
2025
Q2
$15.9M Sell
103,832
-1,502
-1% -$231K 1.6% 18
2025
Q1
$17.5M Sell
105,334
-5,571
-5% -$872K 1.74% 18
2024
Q4
$16M Sell
110,905
-1,425
-1% -$221K 1.59% 19
2024
Q3
$18.2M Sell
112,330
-1,929
-2% -$307K 1.74% 19
2024
Q2
$16.7M Buy
114,259
+75
+0.1% +$11.2K 1.7% 19
2024
Q1
$18.1M Sell
114,184
-358
-0.3% -$57K 1.83% 16
2023
Q4
$18M Sell
114,542
-570
-0.5% -$87.4K 1.93% 14
2023
Q3
$17.9M Buy
115,112
+6,290
+6% +$1.04M 2.11% 14
2023
Q2
$18M Sell
108,822
-90
-0.1% -$14.5K 2.03% 13
2023
Q1
$16.9M Buy
108,912
+650
+0.6% +$105K 2% 13
2022
Q4
$19.1M Sell
108,262
-550
-0.5% -$95K 2.35% 11
2022
Q3
$17.8M Sell
108,812
-135
-0.1% -$22.8K 2.39% 9
2022
Q2
$19.3M Sell
108,947
-250
-0.2% -$44.5K 2.46% 10
2022
Q1
$19.4M Sell
109,197
-880
-0.8% -$150K 2.15% 12
2021
Q4
$18.8M Sell
110,077
-101
-0.1% -$16.5K 1.91% 16
2021
Q3
$17.8M Buy
110,178
+285
+0.3% +$48.6K 1.98% 16
2021
Q2
$18.1M Buy
109,893
+1,056
+1% +$175K 2.03% 14
2021
Q1
$17.9M Buy
108,837
+297
+0.3% +$48.1K 2.15% 13
2020
Q4
$17.1M Sell
108,540
-1,047
-1% -$155K 2.09% 14
2020
Q3
$16.3M Sell
109,587
-2,700
-2% -$400K 2.17% 15
2020
Q2
$15.8M Sell
112,287
-1,833
-2% -$267K 2.29% 12
2020
Q1
$15M Sell
114,120
-537
-0.5% -$76.2K 2.53% 12
2019
Q4
$16.7M Sell
114,657
-2,910
-2% -$395K 2.3% 11
2019
Q3
$15.2M Buy
117,567
+382
+0.3% +$50.3K 2.23% 14
2019
Q2
$16.3M Sell
117,185
-1,035
-0.9% -$143K 2.45% 11
2019
Q1
$16.5M Sell
118,220
-574
-0.5% -$76.9K 2.57% 9
2018
Q4
$15.3M Sell
118,794
-711
-0.6% -$99.2K 2.76% 9
2018
Q3
$16.5M Buy
119,505
+2,210
+2% +$294K 2.57% 8
2018
Q2
$14.2M Buy
117,295
+4,086
+4% +$510K 2.43% 8
2018
Q1
$14.5M Buy
113,209
+1,095
+1% +$148K 2.61% 8
2017
Q4
$15.7M Sell
112,114
-4,375
-4% -$609K 2.68% 7
2017
Q3
$15.1M Buy
116,489
+770
+0.7% +$102K 2.68% 7
2017
Q2
$15.3M Sell
115,719
-1,004
-0.9% -$128K 2.88% 8
2017
Q1
$14.5M Sell
116,723
-250
-0.2% -$29.9K 2.78% 8
2016
Q4
$13.5M Sell
116,973
-1,985
-2% -$229K 2.66% 10
2016
Q3
$14.1M Sell
118,958
-275
-0.2% -$33.4K 2.77% 7
2016
Q2
$14.4M Sell
119,233
-18,450
-13% -$2.1M 2.83% 10
2016
Q1
$14.9M Sell
137,683
-755
-0.5% -$78.2K 2.89% 9
2015
Q4
$14.3M Buy
138,438
+1,272
+0.9% +$128K 2.81% 9
2015
Q3
$12.8M Buy
137,166
+1,000
+0.7% +$96.7K 2.62% 10
2015
Q2
$13.2M Sell
136,166
-678
-0.5% -$67.9K 2.56% 10
2015
Q1
$13.8M Buy
136,844
+280
+0.2% +$28.5K 2.66% 9
2014
Q4
$14.3M Buy
136,564
+3,051
+2% +$322K 2.8% 7
2014
Q3
$14.3M Sell
133,513
-476
-0.4% -$49.4K 2.98% 6
2014
Q2
$14.1M Sell
133,989
-6
-0% -$606 2.96% 6
2014
Q1
$13.1M Sell
133,995
-2,425
-2% -$225K 2.85% 8
2013
Q4
$12.6M Buy
136,420
+2,535
+2% +$234K 2.75% 8
2013
Q3
$11.6M Sell
133,885
-4,292
-3% -$385K 2.79% 8
2013
Q2
$11.9M Buy
+138,177
New +$11.7M 2.97% 7

Other funds holding JNJ

Wendell David Associates's JNJ Position: Q2 2026 in Review

Wendell David Associates reduced its Johnson & Johnson (JNJ) stake by 0.1% in Q2 2026, selling an estimated $23.3K and leaving 100,552 shares worth $25.5M. The position accounts for 2.7% of the portfolio, ranked #9.

Wendell David Associates first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,966 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Wendell David Associates held 100,552 shares of Johnson & Johnson worth $25.5M as of Q2 2026.
  • Wendell David Associates sold 100 Johnson & Johnson shares in Q2 2026, an estimated $23.3K.
  • Johnson & Johnson made up 2.7% of Wendell David Associates's portfolio in Q2 2026, its #9 holding.
  • Wendell David Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,966 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.